Allarity Therapeutics (ALLR) Earnings Date & Reports
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALLR is expected to report earnings to -20 cents per share on November 13
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.02
The last earnings report on August 14 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 7.86K shares outstanding, the current market capitalization sits at 13.85M.